PFE logo

PFE

Pfizer Inc.NYSEHealthcare
$28.33-0.77%OpenMarket Cap: $161.09B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

20.73

PEG

P/B

1.86

P/S

2.57

EV/EBITDA

13.55

DCF Value

$37.59

FCF Yield

5.6%

Div Yield

6.1%

Margins & Returns

Gross Margin

70.3%

Operating Margin

24.7%

Net Margin

12.4%

ROE

8.7%

ROA

9.3%

ROIC

8.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$17.56B$-1.65B$-0.29
FY 2025$62.58B$7.77B$1.36
Q3 2025$16.65B$3.54B$0.62
Q2 2025$14.65B$2.91B$0.51

Analyst Ratings

View All
GuggenheimBuy
2026-03-24
HSBCBuy
2026-03-17
Argus ResearchBuy
2026-03-02
Freedom BrokerBuy
2026-02-09
Cantor FitzgeraldNeutral
2026-02-04

Trading Activity

Insider Trades

View All
BOURLA ALBERTdirector, officer: Chairman & CEO
SellWed Apr 01
Buckley Mortimer Jdirector
SellMon Mar 30
Taraporevala Cyrusdirector
SellMon Mar 30
NARAYEN SHANTANUdirector
SellMon Mar 30
Quincey Jamesdirector
SellMon Mar 30

Congress Trades

View All
Susan M. CollinsBuy
Wed Mar 25

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.39

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Peers